TY  - RPRT
TI  - Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?
AU  - Ester Fonsatti
AU  - Anna Maria Di Giacomo
AU  - Michele Maio
PY  - 2004
DO  - 10.1186/1479-5876-2-21
UR  - https://pubmed.ncbi.nlm.nih.gov/15219237/
ID  - 15219237
ER  -